Global Daclatasvir Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18541710 | Publishing Date : 14-Jun-2021 | No. of pages : 119
Detailed TOC of Global Daclatasvir Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Daclatasvir Market Overview1.1 Daclatasvir Product Overview
1.2 Daclatasvir Market Segment by Type
1.2.1 30mg Tables
1.2.2 60mg Tables
1.3 Global Daclatasvir Market Size by Type
1.3.1 Global Daclatasvir Market Size Overview by Type (2016-2027)
1.3.2 Global Daclatasvir Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Daclatasvir Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Daclatasvir Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Daclatasvir Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Daclatasvir Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Daclatasvir Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Daclatasvir Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Daclatasvir Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Daclatasvir Sales Breakdown by Type (2016-2021)
1.4.2 Europe Daclatasvir Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Daclatasvir Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Daclatasvir Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Daclatasvir Sales Breakdown by Type (2016-2021)
2 Global Daclatasvir Market Competition by Company
2.1 Global Top Players by Daclatasvir Sales (2016-2021)
2.2 Global Top Players by Daclatasvir Revenue (2016-2021)
2.3 Global Top Players Daclatasvir Price (2016-2021)
2.4 Global Top Manufacturers Daclatasvir Manufacturing Base Distribution, Sales Area, Product Type
2.5 Daclatasvir Market Competitive Situation and Trends
2.5.1 Daclatasvir Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Daclatasvir Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daclatasvir as of 2020)
2.7 Date of Key Manufacturers Enter into Daclatasvir Market
2.8 Key Manufacturers Daclatasvir Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Daclatasvir Status and Outlook by Region
3.1 Global Daclatasvir Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Daclatasvir Historic Market Size by Region
3.2.1 Global Daclatasvir Sales in Volume by Region (2016-2021)
3.2.2 Global Daclatasvir Sales in Value by Region (2016-2021)
3.2.3 Global Daclatasvir Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Daclatasvir Forecasted Market Size by Region
3.3.1 Global Daclatasvir Sales in Volume by Region (2022-2027)
3.3.2 Global Daclatasvir Sales in Value by Region (2022-2027)
3.3.3 Global Daclatasvir Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Daclatasvir by Application
4.1 Daclatasvir Market Segment by Application
4.1.1 Hepatitis C Virus (HCV) Genotype 1
4.1.2 Hepatitis C Virus (HCV) Genotype 3
4.1.3 Hepatitis C Virus (HCV) Genotype 4
4.2 Global Daclatasvir Market Size by Application
4.2.1 Global Daclatasvir Market Size Overview by Application (2016-2027)
4.2.2 Global Daclatasvir Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Daclatasvir Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Daclatasvir Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Daclatasvir Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Daclatasvir Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Daclatasvir Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Daclatasvir Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Daclatasvir Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Daclatasvir Sales Breakdown by Application (2016-2021)
4.3.2 Europe Daclatasvir Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Daclatasvir Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Daclatasvir Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Daclatasvir Sales Breakdown by Application (2016-2021)
5 North America Daclatasvir by Country
5.1 North America Daclatasvir Historic Market Size by Country
5.1.1 North America Daclatasvir Sales in Volume by Country (2016-2021)
5.1.2 North America Daclatasvir Sales in Value by Country (2016-2021)
5.2 North America Daclatasvir Forecasted Market Size by Country
5.2.1 North America Daclatasvir Sales in Volume by Country (2022-2027)
5.2.2 North America Daclatasvir Sales in Value by Country (2022-2027)
6 Europe Daclatasvir by Country
6.1 Europe Daclatasvir Historic Market Size by Country
6.1.1 Europe Daclatasvir Sales in Volume by Country (2016-2021)
6.1.2 Europe Daclatasvir Sales in Value by Country (2016-2021)
6.2 Europe Daclatasvir Forecasted Market Size by Country
6.2.1 Europe Daclatasvir Sales in Volume by Country (2022-2027)
6.2.2 Europe Daclatasvir Sales in Value by Country (2022-2027)
7 Asia-Pacific Daclatasvir by Region
7.1 Asia-Pacific Daclatasvir Historic Market Size by Region
7.1.1 Asia-Pacific Daclatasvir Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Daclatasvir Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Daclatasvir Forecasted Market Size by Region
7.2.1 Asia-Pacific Daclatasvir Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Daclatasvir Sales in Value by Region (2022-2027)
8 Latin America Daclatasvir by Country
8.1 Latin America Daclatasvir Historic Market Size by Country
8.1.1 Latin America Daclatasvir Sales in Volume by Country (2016-2021)
8.1.2 Latin America Daclatasvir Sales in Value by Country (2016-2021)
8.2 Latin America Daclatasvir Forecasted Market Size by Country
8.2.1 Latin America Daclatasvir Sales in Volume by Country (2022-2027)
8.2.2 Latin America Daclatasvir Sales in Value by Country (2022-2027)
9 Middle East and Africa Daclatasvir by Country
9.1 Middle East and Africa Daclatasvir Historic Market Size by Country
9.1.1 Middle East and Africa Daclatasvir Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Daclatasvir Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Daclatasvir Forecasted Market Size by Country
9.2.1 Middle East and Africa Daclatasvir Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Daclatasvir Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Daclatasvir Business
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Corporation Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Bristol-Myers Squibb Daclatasvir Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Natco Pharma
10.2.1 Natco Pharma Corporation Information
10.2.2 Natco Pharma Introduction and Business Overview
10.2.3 Natco Pharma Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Bristol-Myers Squibb Daclatasvir Products Offered
10.2.5 Natco Pharma Recent Development
10.3 Zydus Cadila
10.3.1 Zydus Cadila Corporation Information
10.3.2 Zydus Cadila Introduction and Business Overview
10.3.3 Zydus Cadila Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Zydus Cadila Daclatasvir Products Offered
10.3.5 Zydus Cadila Recent Development
10.4 Hetero Drugs
10.4.1 Hetero Drugs Corporation Information
10.4.2 Hetero Drugs Introduction and Business Overview
10.4.3 Hetero Drugs Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Hetero Drugs Daclatasvir Products Offered
10.4.5 Hetero Drugs Recent Development
10.5 Dr Reddy's Laboratories
10.5.1 Dr Reddy's Laboratories Corporation Information
10.5.2 Dr Reddy's Laboratories Introduction and Business Overview
10.5.3 Dr Reddy's Laboratories Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Dr Reddy's Laboratories Daclatasvir Products Offered
10.5.5 Dr Reddy's Laboratories Recent Development
10.6 Cipla
10.6.1 Cipla Corporation Information
10.6.2 Cipla Introduction and Business Overview
10.6.3 Cipla Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Cipla Daclatasvir Products Offered
10.6.5 Cipla Recent Development
10.7 Mylan
10.7.1 Mylan Corporation Information
10.7.2 Mylan Introduction and Business Overview
10.7.3 Mylan Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Mylan Daclatasvir Products Offered
10.7.5 Mylan Recent Development
10.8 Abbott
10.8.1 Abbott Corporation Information
10.8.2 Abbott Introduction and Business Overview
10.8.3 Abbott Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Abbott Daclatasvir Products Offered
10.8.5 Abbott Recent Development
10.9 Emcure Pharmaceuticals
10.9.1 Emcure Pharmaceuticals Corporation Information
10.9.2 Emcure Pharmaceuticals Introduction and Business Overview
10.9.3 Emcure Pharmaceuticals Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Emcure Pharmaceuticals Daclatasvir Products Offered
10.9.5 Emcure Pharmaceuticals Recent Development
10.10 Torrent Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Daclatasvir Product Category, Application and Specification
10.10.3 Torrent Pharmaceuticals Daclatasvir Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Torrent Pharmaceuticals Recent Development
10.11 Biocon
10.11.1 Biocon Corporation Information
10.11.2 Biocon Introduction and Business Overview
10.11.3 Biocon Daclatasvir Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Biocon Daclatasvir Products Offered
10.11.5 Biocon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Daclatasvir Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Daclatasvir Industrial Chain Analysis
11.4 Daclatasvir Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Daclatasvir Distributors
12.3 Daclatasvir Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Daclatasvir Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of 30mg Tables
Table 2. Major Company of 60mg Tables
Table 3. Global Daclatasvir Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 4. Global Daclatasvir Sales by Type (2016-2021) & (K Pcs)
Table 5. Global Daclatasvir Sales Market Share in Volume by Type (2016-2021)
Table 6. Global Daclatasvir Sales by Type (2016-2021) & (US& Million)
Table 7. Global Daclatasvir Market Share in Value by Type (2016-2021)
Table 8. Global Daclatasvir Price by Type (2016-2021) & (USD/Pcs)
Table 9. Global Daclatasvir Sales by Type (2022-2027) & (K Pcs)
Table 10. Global Daclatasvir Sales Market Share in Volume by Type (2022-2027)
Table 11. Global Daclatasvir Sales by Type (2022-2027) & (US$ Million)
Table 12. Global Daclatasvir Sales Market Share in Value by Type (2022-2027)
Table 13. Global Daclatasvir Price by Type (2022-2027) & (USD/Pcs)
Table 14. North America Daclatasvir Sales by Type (2016-2021) & (K Pcs)
Table 15. North America Daclatasvir Sales by Type (2016-2021) & (US$ Million)
Table 16. Europe Daclatasvir Sales (K Pcs) by Type (2016-2021)
Table 17. Europe Daclatasvir Sales by Type (2016-2021) & (US$ Million)
Table 18. Asia-Pacific Daclatasvir Sales (K Pcs) by Type (2016-2021)
Table 19. Asia-Pacific Daclatasvir Sales by Type (2016-2021) & (US$ Million)
Table 20. Latin America Daclatasvir Sales (K Pcs) by Type (2016-2021)
Table 21. Latin America Daclatasvir Sales by Type (2016-2021) & (US$ Million)
Table 22. Middle East and Africa Daclatasvir Sales (K Pcs) by Type (2016-2021)
Table 23. Middle East and Africa Daclatasvir Sales by Type (2016-2021) & (US$ Million)
Table 24. Global Daclatasvir Sales by Company (2016-2021) & (K Pcs)
Table 25. Global Daclatasvir Sales Share by Company (2016-2021)
Table 26. Global Daclatasvir Revenue by Company (2016-2021) & (US$ Million)
Table 27. Global Daclatasvir Revenue Share by Company (2016-2021)
Table 28. Global Market Daclatasvir Price by Company (2016-2021) & (USD/Pcs)
Table 29. Global Daclatasvir Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Daclatasvir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daclatasvir as of 2020
Table 32. Date of Key Manufacturers Enter into Daclatasvir Market
Table 33. Key Manufacturers Daclatasvir Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Daclatasvir Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 36. Global Daclatasvir Sales by Region (2016-2021) & (K Pcs)
Table 37. Global Daclatasvir Sales Market Share in Volume by Region (2016-2021)
Table 38. Global Daclatasvir Sales by Region (2016-2021) & (US$ Million)
Table 39. Global Daclatasvir Sales Market Share in Value by Region (2016-2021)
Table 40. Global Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 41. Global Daclatasvir Sales by Region (2022-2027) & (K Pcs)
Table 42. Global Daclatasvir Sales Market Share in Volume by Region (2022-2027)
Table 43. Global Daclatasvir Sales by Region (2022-2027) & (US$ Million)
Table 44. Global Daclatasvir Sales Market Share in Value by Region (2022-2027)
Table 45. Global Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027)
Table 46. Global Daclatasvir Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 47. Global Daclatasvir Sales by Application (2016-2021) & (K Pcs)
Table 48. Global Daclatasvir Sales Market Share in Volume by Application (2016-2021)
Table 49. Global Daclatasvir Sales by Application (2016-2021) & (US$ Million)
Table 50. Global Daclatasvir Sales Market Share in Value by Application (2016-2021)
Table 51. Global Daclatasvir Price by Application (2016-2021) & (USD/Pcs)
Table 52. Global Daclatasvir Sales by Application (2022-2027) & (K Pcs)
Table 53. Global Daclatasvir Sales Market Share in Volume by Application (2022-2027)
Table 54. Global Daclatasvir Sales by Application (2022-2027) & (US$ Million)
Table 55. Global Daclatasvir Sales Market Share in Value by Application (2022-2027)
Table 56. Global Daclatasvir Price by Application (2022-2027) & (USD/Pcs)
Table 57. North America Daclatasvir Sales by Application (2016-2021) (K Pcs)
Table 58. North America Daclatasvir Sales by Application (2016-2021) & (US$ Million)
Table 59. North America Daclatasvir Sales Market Share in Value by Application in 2020
Table 60. Europe Daclatasvir Sales by Application (2016-2021) (K Pcs)
Table 61. Europe Daclatasvir Sales by Application (2016-2021) & (US$ Million)
Table 62. Europe Daclatasvir Sales Market Share in Value by Application in 2020
Table 63. Asia-Pacific Daclatasvir Sales by Application (2016-2021) (K Pcs)
Table 64. Asia-Pacific Daclatasvir Sales by Application (2016-2021) & (US$ Million)
Table 65. Asia-Pacific Daclatasvir Sales Market Share in Value by Application in 2020
Table 66. Latin America Daclatasvir Sales by Application (2016-2021) (K Pcs)
Table 67. Latin America Daclatasvir Sales by Application (2016-2021) & (US$ Million)
Table 68. Latin America Daclatasvir Sales Market Share in Value by Application in 2020
Table 69. Middle East and Africa Daclatasvir Sales by Application (2016-2021) (K Pcs)
Table 70. Middle East and Africa Daclatasvir Sales by Application (2016-2021) & (US$ Million)
Table 71. Middle East and Africa Daclatasvir Sales Market Share in Value by Application in 2020
Table 72. North America Daclatasvir Sales by Country (2016-2021) & (K Pcs)
Table 73. North America Daclatasvir Sales Market Share in Volume by Country (2016-2021)
Table 74. North America Daclatasvir Sales by Country (2016-2021) & (US$ Million)
Table 75. North America Daclatasvir Sales Market Share in Value by Country (2016-2021)
Table 76. North America Daclatasvir Sales by Country (2022-2027) & (K Pcs)
Table 77. North America Daclatasvir Sales Market Share in Volume by Country (2022-2027)
Table 78. North America Daclatasvir Sales by Country (2022-2027) & (US$ Million)
Table 79. North America Daclatasvir Sales Market Share in Value by Country (2022-2027)
Table 80. Europe Daclatasvir Sales by Country (2016-2021) & (K Pcs)
Table 81. Europe Daclatasvir Sales Market Share in Volume by Country (2016-2021)
Table 82. Europe Daclatasvir Sales by Country (2016-2021) & (US$ Million)
Table 83. Europe Daclatasvir Sales Market Share in Value by Country (2016-2021)
Table 84. Europe Daclatasvir Sales by Country (2022-2027) & (K Pcs)
Table 85. Europe Daclatasvir Sales Market Share in Volume by Country (2022-2027)
Table 86. Europe Daclatasvir Sales by Country (2022-2027) & (US$ Million)
Table 87. Europe Daclatasvir Sales Market Share in Value by Country (2022-2027)
Table 88. Asia-Pacific Daclatasvir Sales by Region (2016-2021) & (K Pcs)
Table 89. Asia-Pacific Daclatasvir Sales Market Share in Volume by Region (2016-2021)
Table 90. Asia-Pacific Daclatasvir Sales by Region (2016-2021) & (US$ Million)
Table 91. Asia-Pacific Daclatasvir Sales Market Share in Value by Region (2016-2021)
Table 92. Asia-Pacific Daclatasvir Sales by Region (2022-2027) & (K Pcs)
Table 93. Asia-Pacific Daclatasvir Sales Market Share in Volume by Region (2022-2027)
Table 94. Asia-Pacific Daclatasvir Sales by Region (2022-2027) & (US$ Million)
Table 95. Asia-Pacific Daclatasvir Sales Market Share in Value by Region (2022-2027)
Table 96. Latin America Daclatasvir Sales by Country (2016-2021) & (K Pcs)
Table 97. Latin America Daclatasvir Sales Market Share in Volume by Country (2016-2021)
Table 98. Latin America Daclatasvir Sales by Country (2016-2021) & (US$ Million)
Table 99. Latin America Daclatasvir Sales Market Share in Value by Country (2016-2021)
Table 100. Latin America Daclatasvir Sales by Country (2022-2027) & (K Pcs)
Table 101. Latin America Daclatasvir Sales Market Share in Volume by Country (2022-2027)
Table 102. Latin America Daclatasvir Sales by Country (2022-2027) & (US$ Million)
Table 103. Latin America Daclatasvir Sales Market Share in Value by Country (2022-2027)
Table 104. Middle East and Africa Daclatasvir Sales by Country (2016-2021) & (K Pcs)
Table 105. Middle East and Africa Daclatasvir Sales Market Share in Volume by Country (2016-2021)
Table 106. Middle East and Africa Daclatasvir Sales by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Daclatasvir Sales Market Share in Value by Country (2016-2021)
Table 108. Middle East and Africa Daclatasvir Sales by Country (2022-2027) & (K Pcs)
Table 109. Middle East and Africa Daclatasvir Sales Market Share in Volume by Country (2022-2027)
Table 110. Middle East and Africa Daclatasvir Sales by Country (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Daclatasvir Sales Market Share in Value by Country (2022-2027)
Table 112. Bristol-Myers Squibb Corporation Information
Table 113. Bristol-Myers Squibb Introduction and Business Overview
Table 114. Bristol-Myers Squibb Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 115. Bristol-Myers Squibb Daclatasvir Product
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Natco Pharma Corporation Information
Table 118. Natco Pharma Introduction and Business Overview
Table 119. Natco Pharma Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 120. Natco Pharma Daclatasvir Product
Table 121. Natco Pharma Recent Development
Table 122. Zydus Cadila Corporation Information
Table 123. Zydus Cadila Introduction and Business Overview
Table 124. Zydus Cadila Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 125. Zydus Cadila Daclatasvir Product
Table 126. Zydus Cadila Recent Development
Table 127. Hetero Drugs Corporation Information
Table 128. Hetero Drugs Introduction and Business Overview
Table 129. Hetero Drugs Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 130. Hetero Drugs Daclatasvir Product
Table 131. Hetero Drugs Recent Development
Table 132. Dr Reddy's Laboratories Corporation Information
Table 133. Dr Reddy's Laboratories Introduction and Business Overview
Table 134. Dr Reddy's Laboratories Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 135. Dr Reddy's Laboratories Daclatasvir Product
Table 136. Dr Reddy's Laboratories Recent Development
Table 137. Cipla Corporation Information
Table 138. Cipla Introduction and Business Overview
Table 139. Cipla Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 140. Cipla Daclatasvir Product
Table 141. Cipla Recent Development
Table 142. Mylan Corporation Information
Table 143. Mylan Introduction and Business Overview
Table 144. Mylan Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 145. Mylan Daclatasvir Product
Table 146. Mylan Recent Development
Table 147. Abbott Corporation Information
Table 148. Abbott Introduction and Business Overview
Table 149. Abbott Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 150. Abbott Daclatasvir Product
Table 151. Abbott Recent Development
Table 152. Emcure Pharmaceuticals Corporation Information
Table 153. Emcure Pharmaceuticals Introduction and Business Overview
Table 154. Emcure Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 155. Emcure Pharmaceuticals Daclatasvir Product
Table 156. Emcure Pharmaceuticals Recent Development
Table 157. Torrent Pharmaceuticals Corporation Information
Table 158. Torrent Pharmaceuticals Introduction and Business Overview
Table 159. Torrent Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 160. Torrent Pharmaceuticals Daclatasvir Product
Table 161. Torrent Pharmaceuticals Recent Development
Table 162. Biocon Corporation Information
Table 163. Biocon Introduction and Business Overview
Table 164. Biocon Daclatasvir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 165. Biocon Daclatasvir Product
Table 166. Biocon Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Daclatasvir Market Trends
Table 170. Daclatasvir Market Drivers
Table 171. Daclatasvir Market Challenges
Table 172. Daclatasvir Market Restraints
Table 173. Daclatasvir Distributors List
Table 174. Daclatasvir Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Daclatasvir Product Picture
Figure 2. Global Daclatasvir Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Daclatasvir Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Daclatasvir Sales Status and Outlook (2016-2027) & (K Pcs)
Figure 5. Product Picture of 30mg Tables
Figure 6. Global 30mg Tables Sales YoY Growth (2016-2021) & (K Pcs)
Figure 7. Product Picture of 60mg Tables
Figure 8. Global 60mg Tables Sales YoY Growth (2016-2021) & (K Pcs)
Figure 9. Global Daclatasvir Sales by Type (2016-2027) & (US$ Million)
Figure 10. Global Daclatasvir Sales Market Share in Volume by Type (2016-2021)
Figure 11. Global Daclatasvir Sales Market Share in Value by Type (2016-2021)
Figure 12. Global Daclatasvir Sales Market Share in Volume by Type (2022-2027)
Figure 13. Global Daclatasvir Sales Market Share in Value by Type (2022-2027)
Figure 14. North America Daclatasvir Sales Market Share in Volume by Type in 2020
Figure 15. North America Daclatasvir Sales Market Share in Value by Type in 2020
Figure 16. Europe Daclatasvir Sales Market Share in Volume by Type in 2020
Figure 17. Europe Daclatasvir Sales Market Share in Value by Type in 2020
Figure 18. Asia-Pacific Daclatasvir Sales Market Share in Volume by Type in 2020
Figure 19. Asia-Pacific Daclatasvir Sales Market Share in Value by Type in 2020
Figure 20. Latin America Daclatasvir Sales Market Share in Volume by Type in 2020
Figure 21. Latin America Daclatasvir Sales Market Share in Value by Type in 2020
Figure 22. Middle East and Africa Daclatasvir Sales Market Share in Volume by Type in 2020
Figure 23. Middle East and Africa Daclatasvir Sales Market Share in Value by Type in 2020
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Daclatasvir Sales in 2020
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Daclatasvir Revenue in 2020
Figure 26. Daclatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 27. Product Picture of Hepatitis C Virus (HCV) Genotype 1
Figure 28. Global Hepatitis C Virus (HCV) Genotype 1 Sales YoY Growth (2016-2027) & (K Pcs)
Figure 29. Product Picture of Hepatitis C Virus (HCV) Genotype 3
Figure 30. Global Hepatitis C Virus (HCV) Genotype 3 Sales YoY Growth (2016-2027) & (K Pcs)
Figure 31. Product Picture of Hepatitis C Virus (HCV) Genotype 4
Figure 32. Global Hepatitis C Virus (HCV) Genotype 4 Sales YoY Growth (2016-2027) & (K Pcs)
Figure 33. Global Daclatasvir Sales by Application (2016-2027) & (US$ Million)
Figure 34. Global Daclatasvir Sales Market Share in Volume by Application (2016-2021)
Figure 35. Global Daclatasvir Sales Market Share in Value by Application (2016-2021)
Figure 36. Global Daclatasvir Sales Market Share in Volume by Application (2022-2027)
Figure 37. North America Daclatasvir Sales Market Share in Volume by Application in 2020
Figure 38. Latin America Daclatasvir Sales Market Share in Value by Application in 2020
Figure 39. Middle East and Africa Daclatasvir Sales Market Share in Value by Application in 2020
Figure 40. Key Raw Materials Price
Figure 41. Daclatasvir Manufacturing Cost Structure
Figure 42. Daclatasvir Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Daclatasvir Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bristol-Myers SquibbNatco Pharma
Zydus Cadila
Hetero Drugs
Dr Reddy's Laboratories
Cipla
Mylan
Abbott
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Biocon